Eli Lilly Sues Businesses Selling Knockoff Versions of Mounjaro

Eli Lilly & Co. is suing medical spas, wellness centers and compounding pharmacies in various US states that sell unapproved versions of its blockbuster diabetes drug Mounjaro, which is frequently used off-label for weight loss.

In lawsuits Lilly said it filed in federal courts spanning several states, it accused four businesses of selling compounded versions of Mounjaro violating state laws because the drugs lack approval from the US Food and Drug Administration. Lilly is accusing another six companies, mostly medical spas and wellness centers, of trademark violations, false advertising and unfair competition by selling knockoff drugs under the Mounjaro name. ...